Erica R. Appleman

Erica R. Appleman

Auto-generated profile, based on publicly available information

Erica R. Appleman

Signant Health, Blue Bell, PA USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2021 in The Clinical Neuropsychologist
Verified
Journal Article
Closed access
EAErica R. Appleman
Erica R. Appleman
MOMaureen K. O’cOnnor
Maureen K. O’cOnnor
SBSarah J. Boucher
Sarah J. Boucher
RRRamona Rostami
Ramona Rostami
SSSara K. Sullivan
Sara K. Sullivan
MKMalissa Kraft
Malissa Kraft
Objective: Telehealth offers the opportunity to address a growing need to improve access to specialty services, such as neuropsychology, particularly for older adults and those in rural areas. Initial research has examined the validity and acceptability of teleneuropsychology (teleNP) in research settings, but there is less information about teleNP implementation in clinical practice. Here we describe the development of a teleNP clinic and compare patient satisfaction to those completing in-person neuropsychological evaluations. Method: A teleNP clinic was developed at the VA Bedford Healthcare System to serve older Veterans with referral questions focused on cognitive aging concerns. Patients presented to affiliated VA satellite clinics and were connected to neuropsychology clinicians at the main hospital campus through synchronous video. An evaluation battery was compiled to closely approximate in-person evaluations. Trained staff members at the satellite clinic assisted with administration of select tasks. Patient satisfaction was evaluated using a self-report questionnaire and responses were compared to a group undergoing in-person neuropsychological evaluations. Results: Self-reported satisfaction was high for all aspects of the patient experience, with no significant difference found between teleNP (n = 67) and in-person (n = 64) groups. In particular, 90% of patients in the teleNP group and 98% of patients in the in-person group agreed or strongly agreed with the statement, “I was overall satisfied with this visit.”. Conclusions: TeleNP is a feasible and acceptable alternative to traditional in-person neuropsychological evaluations in clinical practice focused on older adults. Future research should continue to validate evaluation measures used in telehealth settings, identify the populations that would benefit most from teleNP services, and explore the expansion of teleNP services.

31 March 2020 in Clinical Gerontologist
Verified
Journal Article
Closed access
EAErica R. Appleman
Erica R. Appleman
MOMaureen K. O’cOnnor
Maureen K. O’cOnnor
WRWhitney Rockefeller
Whitney Rockefeller
PMPeter Morin
Peter Morin
LMLauren R. Moo
Lauren R. Moo
Objectives: This pilot project aimed to explore a new model of healthcare delivery to older adult medically complex Veterans by combining telehealth technology with an interdisciplinary medical team operating in real time. Methods: The Geriatric-Interdisciplinary Mobile Patient Access Team (G-IMPACT) was comprised of a field team including a nurse practitioner and technology assistant who visited enrolled patients in their homes using synchronous video to link to a suite of geriatric specialists in a video-enabled room at a Veterans Affairs hospital. Clinicians interacted with patients, caregivers, and each other to develop mutually agreed upon treatment plans that were then immediately implemented in the field. Results: 11 total visits were conducted with 9 Veteran patients aged 55–91 (mean = 75.3 years). Both patients and clinicians reported a high level of satisfaction across multiple metrics, including visit quality, and positive indirect indicators of effectiveness were apparent from qualitative data. Conclusions: Nurse practitioner facilitated video visits allowed geriatric patients to meet with multiple specialists simultaneously with both high patient satisfaction and increased real-time care coordination. Clinical Implications: This project identified challenges and opportunities afforded by this type of real-time telehealth care delivery and can inform the development of future interdisciplinary mobile medical teams.

1 June 2015 in Sleep Health
Verified
Journal Article
Closed access
EAErica R. Appleman
Erica R. Appleman
KGKarina Stavitsky Gilbert
Karina Stavitsky Gilbert
RARhoda Au
Rhoda Au

1 January 2011 in Parkinson's Disease
Verified
Journal Article
Open access
PDF file
EAErica R. Appleman
Erica R. Appleman
KSKarina Stavitsky
Karina Stavitsky
ACAlice Cronin-Golomb
Alice Cronin-Golomb
Parkinson's disease (PD) presents with extensive heterogeneity in symptomatology, inviting examination of disease subtypes. One significant categorization is by whether patients present at onset with tremor as the dominant symptom (TD) or with nontremor symptoms (NTD). We examined differences in quality of life between TD and NTD patients using the Parkinson's Disease Questionnaire-39 (PDQ-39), correlating performance with aspects of motor function as indexed by the Unified Parkinson's Disease Rating Scale (UPDRS). Participants included 35 nondemented individuals (19 TD, 16 NTD) matched on clinical and demographic characteristics. NTD had significantly lower overall PDQ-39 scores, particularly for the mobility subscale. Several UPDRS subscale scores significantly correlated with quality of life, especially for NTD. Further, the correlations were driven by nontremor type symptoms, even in TD patients. Determining reliable subtypes of PD may aid in prognosis and treatment optimization, thereby enhancing quality of life in afflicted individuals.

26 September 2021 in Exploration of Targeted Anti-tumor Therapy
Verified
Journal Article
Open access
PDF file
TMTaylor Maynard
Taylor Maynard
EAErica Appleman
Erica Appleman
ACAlice Cronin-Golomb
Alice Cronin-Golomb
SNSandra A Neargarder
Sandra A Neargarder
Aim: Smartphone technology is increasingly used by the public to assess sleep. Specific features of some sleep-tracking applications are comparable to actigraphy in objectively monitoring sleep. The clinical utility of smartphone apps should be investigated further to increase access to convenient means of monitoring sleep. Methods: Smartphone and subjective sleep measures were administered to 29 community-dwelling healthy adults [aged 20-67, Mean (M) = 26.8; 18 women, 11 men], and actigraphy to 19 of them. Total sleep time (TST) and sleep efficiency were measured with actigraphy and the Sleep Time app (Azumio Inc.). Sleep diaries captured subjective TST and sleep efficiency, and the Epworth Sleepiness Scale and Pittsburgh Sleep Quality Index provided self-report data. An exit questionnaire was administered to examine app feasibility and likelihood of future use. Results: The app significantly overestimated TST when compared to actigraphy. There was no significant difference in sleep efficiency between methodologies. There was also no significant difference between TST recorded through the app and through sleep diaries. Participants’ self-reported ease of use of the smartphone app positively correlated with likelihood of future use. Conclusions: Based on the current findings, future research is needed to investigate the utility and feasibility of multiple smartphone applications in monitoring sleep in healthy and clinical populations.

25 December 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
EAErica R. Appleman
Erica R. Appleman
SMSayaka Machizawa
Sayaka Machizawa
JSJessica Stenclik
Jessica Stenclik
RKRujvi Kamat
Rujvi Kamat
AIAndrei Iacob
Andrei Iacob
Background: In addition to measures of cognition, global Alzheimer’s disease (AD) clinical trials commonly include measures to assess functional status (activities of daily living; ADLs) and quality of life (QoL) reported by participants and study partners. Most common assessments were validated with North American, White, English‐speaking populations and research suggests that these are not free from cultural and linguistic influence. ADLs and QoL may exhibit regional differences due to socioeconomic and cultural factors. It is important to understand how geo‐cultural factors influence these measures, which are often used as trial efficacy endpoints. In this study, we examined the impact of geo‐cultural region on ADCS‐MCI‐ADL and QoL‐AD when considering baseline cognitive status.Method: This study included electronic ADCS‐MCI‐ADL, QoL‐AD, and ADAS‐Cog data from two multi‐national AD clinical trials of participants with prodromal to mild AD. Data were collected from three geo‐cultural regions: Asia (n = 688); Western Europe (WE; n = 589); and North America (NA; n = 1925). Participants were stratified into five cohorts based on ADAS‐Cog13 scores.Result: QoL‐AD Study Partner and AD Participant scores varied significantly across geo‐cultural regions (Kruskal‐Wallis test; p<0.0001). Both study partner‐reported and participant reported QoL‐AD scores in Asia were lower than scores in NA and WE for all ADAS‐Cog13 cohorts (Dunn’s test; p 40th percentile), study partner‐reported QoL‐AD scores in NA were significantly higher than those in WE (Dunn’s test; p<0.05), but there was not significant difference on the participant‐reported QoL‐AD scores between these regions. ADCS‐MCI‐ADL scores were not significantly different across groups.Conclusion: Our study found that QoL‐AD, but not ADCS‐MCI‐ADL scores differed significantly across geo‐cultural regions when considering baseline cognitive performance. Both participant and study‐partner reported QoL was lower in Asia than in WE and NA. Cross‐regional differences in QoL may also be moderated by baseline cognitive performance. Different social norms and aging expectation, healthcare resources, and trial participation may have contributed to the regional variance observed. Future studies should examine if specific constructs are more contextually dependent on the local culture.